Immunodominant Regions for T Helper-cell Sensitization on the Human Nicotinic Receptor Alpha Subunit in Myasthenia Gravis

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1990 Oct 1

PMID 2145582

Citations 21

Authors

M P Protti

A A Manfredi

C Straub

J F Howard Jr

Affiliations

Soon will be listed here.

Abstract

In myasthenia gravis an autoimmune response against the nicotinic acetylcholine receptor (AChR) occurs. The alpha subunit of the AChR contains both the epitope(s) that dominates the antibody response (main immunogenic region) and epitopes involved in T helper cell sensitization. In this study, overlapping synthetic peptides corresponding to the complete AChR alpha-subunit sequence were used to propagate polyclonal AChR-specific T helper cell lines from four myasthenic patients of different HLA types. Response of the T helper lines to the individual peptides was studied. Four immunodominant sequence segments were identified--i.e., residues 48-67, 101-120, 304-322, and 419-437. These regions did not include residues known to form the main immunogenic region or the cholinergic binding site, and they frequently contained sequence motifs that have been proposed to be related to T-epitope formation.

Citing Articles

Antigen-specific immune therapy (CNP-106) for treatment of generalised myasthenia gravis: rationale and design of first-in-human randomised controlled trial.

G Brew S, Frey M, P McCarthy D, Elhofy A, Nowak R BMJ Neurol Open. 2024; 6(2):e000836.

PMID: 39720510 PMC: 11667273. DOI: 10.1136/bmjno-2024-000836.

A Recombinant Acetylcholine Receptor α1 Subunit Extracellular Domain Is a Promising New Drug Candidate for Treatment Of Myasthenia Gravis.

Lazaridis K, Fernandez-Santoscoy M, Baltatzidou V, Andersson J, Christison R, Grunberg J Front Immunol. 2022; 13:809106.

PMID: 35720339 PMC: 9204200. DOI: 10.3389/fimmu.2022.809106.

Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis.

Guptill J, Soni M, Meriggioli M Neurotherapeutics. 2015; 13(1):118-31.

PMID: 26510558 PMC: 4720661. DOI: 10.1007/s13311-015-0398-y.

Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.

Yi J, Guidon A, Sparks S, Osborne R, Juel V, Massey J J Autoimmun. 2014; 52:130-8.

PMID: 24378287 PMC: 4230445. DOI: 10.1016/j.jaut.2013.12.005.

Functional defect in regulatory T cells in myasthenia gravis.

Thiruppathi M, Rowin J, Jiang Q, Sheng J, Prabhakar B, Meriggioli M Ann N Y Acad Sci. 2012; 1274:68-76.

PMID: 23252899 PMC: 3531815. DOI: 10.1111/j.1749-6632.2012.06840.x.

References

Clark D, Macmurchie D, Elliott E, Wolcott R, LANDEL A, RAFTERY M . Elapid neurotoxins. Purification, characterization, and immunochemical studies of -bungarotoxin. Biochemistry. 1972; 11(9):1663-8. DOI: 10.1021/bi00759a020. View

Protti M, Manfredi A, Straub C, Wu X, Howard Jr J . Use of synthetic peptides to establish anti-human acetylcholine receptor CD4+ cell lines from myasthenia gravis patients. J Immunol. 1990; 144(5):1711-20. View

Blanchard S, Quast U, Reed K, Lee T, Schimerlik M, Vandlen R . Interaction of [125I]-alpha-bungarotoxin with acetylcholine receptor from Torpedo californica. Biochemistry. 1979; 18(10):1875-83. DOI: 10.1021/bi00577a005. View

Elliott J, Dunn S, Blanchard S, RAFTERY M . Specific binding of perhydrohistrionicotoxin to Torpedo acetylcholine receptor. Proc Natl Acad Sci U S A. 1979; 76(6):2576-9. PMC: 383650. DOI: 10.1073/pnas.76.6.2576. View

Kurnick J, Ostberg L, Stegagno M, Kimura A, Orn A, Sjoberg O . A rapid method for the separation of functional lymphoid cell populations of human and animal origin on PVP-silica (Percoll) density gradients. Scand J Immunol. 1979; 10(6):563-73. DOI: 10.1111/j.1365-3083.1979.tb01391.x. View

Elliott J, Blanchard S, Wu W, Miller J, Strader C, Hartig P . Purification of Torpedo californica post-synaptic membranes and fractionation of their constituent proteins. Biochem J. 1980; 185(3):667-77. PMC: 1161444. DOI: 10.1042/bj1850667. View

Lindstrom J, Einarson B, Tzartos S . Production and assay of antibodies to acetylcholine receptors. Methods Enzymol. 1981; 74 Pt C:432-60. DOI: 10.1016/0076-6879(81)74031-x. View

Tzartos S, Seybold M, Lindstrom J . Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc Natl Acad Sci U S A. 1982; 79(1):188-92. PMC: 345688. DOI: 10.1073/pnas.79.1.188. View

Noda M, Furutani Y, Takahashi H, Toyosato M, Tanabe T, Shimizu S . Cloning and sequence analysis of calf cDNA and human genomic DNA encoding alpha-subunit precursor of muscle acetylcholine receptor. Nature. 1983; 305(5937):818-23. DOI: 10.1038/305818a0. View

10.

Romain P, Morimoto C, Daley J, Palley L, Reinherz E, Schlossman S . Reactivity of inducer cell subsets and T8-cell activation during the human autologous mixed lymphocyte reaction. Clin Immunol Immunopathol. 1984; 30(1):117-28. DOI: 10.1016/0090-1229(84)90012-6. View

11.

Heinrikson R, Meredith S . Amino acid analysis by reverse-phase high-performance liquid chromatography: precolumn derivatization with phenylisothiocyanate. Anal Biochem. 1984; 136(1):65-74. DOI: 10.1016/0003-2697(84)90307-5. View

12.

Kotani H, Takada S, Ueda Y, Murakawa Y, Suzuki N, Sakane T . Activation of immune regulatory circuits among OKT4+ cells by autologous mixed lymphocyte reactions. Clin Exp Immunol. 1984; 56(2):390-8. PMC: 1536222. View

13.

Hohlfeld R, Toyka K, Heininger K, Grosse-Wilde H, Kalies I . Autoimmune human T lymphocytes specific for acetylcholine receptor. Nature. 1984; 310(5974):244-6. DOI: 10.1038/310244a0. View

14.

Engel A . Myasthenia gravis and myasthenic syndromes. Ann Neurol. 1984; 16(5):519-34. DOI: 10.1002/ana.410160502. View

15.

Houghten R . General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci U S A. 1985; 82(15):5131-5. PMC: 390513. DOI: 10.1073/pnas.82.15.5131. View

16.

Delisi C, Berzofsky J . T-cell antigenic sites tend to be amphipathic structures. Proc Natl Acad Sci U S A. 1985; 82(20):7048-52. PMC: 391307. DOI: 10.1073/pnas.82.20.7048. View

17.

Wilson P, Lentz T, Hawrot E . Determination of the primary amino acid sequence specifying the alpha-bungarotoxin binding site on the alpha subunit of the acetylcholine receptor from Torpedo californica. Proc Natl Acad Sci U S A. 1985; 82(24):8790-4. PMC: 391523. DOI: 10.1073/pnas.82.24.8790. View

18.

Hohlfeld R, Kalies I, Kohleisen B, Heininger K, Toyka K . Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines. Neurology. 1986; 36(5):618-21. DOI: 10.1212/wnl.36.5.618. View

19.

McCarthy M, Earnest J, Young E, Choe S, Stroud R . The molecular neurobiology of the acetylcholine receptor. Annu Rev Neurosci. 1986; 9:383-413. DOI: 10.1146/annurev.ne.09.030186.002123. View

20.

Neumann D, Barchan D, Fridkin M, Fuchs S . Analysis of ligand binding to the synthetic dodecapeptide 185-196 of the acetylcholine receptor alpha subunit. Proc Natl Acad Sci U S A. 1986; 83(23):9250-3. PMC: 387113. DOI: 10.1073/pnas.83.23.9250. View